Innovation

Antibody against P70 Surface Antigen of M. hyorhinis (clone AB3P)

University of Missouri System: University of Missouri-Columbia
posted on 07/22/2011

Mycoplasma hyorhinis is the primary agent of pig pneumonia found world-wide and results in large economic losses. MU inventors have developed a mouse monoclonal antibody that works with a variety of applications to detect M. hyorhinis such as the testing, diagnosis and monitoring of infected animals as well as possible vaccine development. It is an ideal product for potential commercial utilization.

The respiratory infection caused by M. hyorhinis may be chronic, have high morbidity and low mortality rates, and cause significant economic losses. In addition, mycoplasmas can be human pathogens and Mycoplasma hyorhinis has been linked to gastric cancer and other gastric diseases.

The current invention developed by researchers at University of Missouri is a mouse monoclonal antibody against the P70 surface protein antigen of Mycoplasma hyorhinis.

Suggested Uses

  • Testing, diagnosis and monitoring of infected animals
  • Development of a vaccine against M. hyorhinis
  • Monitoring of cell lines for contamination by M. hyorhinis

Advantages

  • Hybridoma cell line available
  • IgG1 k isotype allows for easy affinity purification
  • P70 is constitutively expressed on M. hyorhinis
  • The antibody does not cross-react with other mycoplasma species
  • Works with ELISA, Western, immunohistochemistry, and more

Innovation Details
 

Detailed Description

STATE OF DEVELOPMENT
Ready to use

LICENSING POTENTIAL
University seeks licensee with potential to commercialize

PATENT STATUS
No patent application on file

TECHNOLOGY INNOVATOR
Kim S. Wise

File Number: 11UMC027 

Disease: Respiratory and Pulmonary System

Other Information:

TECHNOLOGY MANAGER CONTACT

Harriet F. Francis, MS, JD
Senior Licensing Associate
Email: francish@missouri.edu
Phone: 573-884-0374

This innovation currently is not available for online licensing.
Please contact Harriet Francis at University of Missouri Office of Technology and Industry Relations for more information.


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Harriet Francis at University of Missouri System: University of Missouri-Columbia for more information.

Request more info via email request more info
People

Case Manager:

Harriet Francis Harriet Francis

Innovations (29)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...